Largest pharmaceuticals by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
AbbVie has the lowest figure of the 61 pharmaceuticals ranked by net assets, at -AED 12B, followed by BridgeBio Pharma (-AED 7.7B) and Cytokinetics (-AED 2.4B). Figures as of 18 Nov 2026, 16:06 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- AbbVie-AED 12B
- Median
- AED 3.2B
- Combined market value
- AED 18.68T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Net assets ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | -AED 12B | AED 1.87T | AED 1,059.32 | 1.50% down | 26% up | ||
| 2 | BridgeBio PharmaBBIO · Health Care | -AED 7.7B | AED 55.8B | AED 286.31 | 1.50% up | 17% up | ||
| 3 | CytokineticsCYTK · Health Care | -AED 2.4B | AED 26.2B | AED 188.27 | 0.76% down | 20% down | ||
| 4 | PTC TherapeuticsPTCT · Health Care | -AED 754.1M | AED 18.6B | AED 222.39 | 0.31% up | 20% down | ||
| 5 | Ascendis PharmaASND · Health Care | -AED 663.5M | AED 65.2B | AED 993.37 | 0.27% down | 28% up | ||
| 6 | VeradermicsMANE · Health Care | -AED 444.5M | AED 19.3B | AED 458.19 | 0.71% down | 233% up | ||
| 7 | Amneal PharmaceuticalsAMRX · Health Care | -AED 260M | AED 27.7B | AED 79.41 | 2.37% up | 83% up | ||
| 8 | Axsome TherapeuticsAXSM · Health Care | AED 324.3M | AED 25.8B | AED 490.66 | 1.74% down | 7% down | ||
| 9 | Travere TherapeuticsTVTX · Health Care | AED 421.8M | AED 17.7B | AED 184.78 | 1.55% down | 44% up | ||
| 10 | Rhythm PharmaceuticalsRYTM · Health Care | AED 510.8M | AED 29.7B | AED 428.57 | 0.06% up | 13% up | ||
| 11 | Mirum PharmaceuticalsMIRM · Health Care | AED 1.2B | AED 22B | AED 336.38 | 0.40% down | 31% up | ||
| 12 | ErascaERAS · Health Care | AED 1.2B | AED 17.1B | AED 48.67 | 4.61% down | 403% up | ||
| 13 | Definium TherapeuticsDFTX · Health Care | AED 1.2B | AED 14.3B | AED 104.64 | 3.03% down | 169% up | ||
| 14 | Arrowhead PharmaceuticalsARWR · Health Care | AED 1.7B | AED 22.6B | AED 159.59 | 1.07% up | 10% up | ||
| 15 | Oruka TherapeuticsORKA · Health Care | AED 1.7B | AED 24.1B | AED 354.99 | 0.34% up | 241% up | ||
| 16 | Ionis PharmaceuticalsIONS · Health Care | AED 1.8B | AED 16.7B | AED 100.20 | 1.19% up | 64% down | ||
| 17 | Dianthus TherapeuticsDNTH · Health Care | AED 1.8B | AED 17.9B | AED 317.47 | 0.63% down | 113% up | ||
| 18 | ABIVAXABVX · Health Care | AED 1.9B | AED 26.9B | AED 307.22 | 1.88% up | 27% down | ||
| 19 | Edgewise TherapeuticsEWTX · Health Care | AED 1.9B | AED 16.4B | AED 149.77 | 3.00% down | 88% up | ||
| 20 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | AED 2.1B | AED 27.8B | AED 353.48 | 1.19% up | 126% up | ||
| 21 | Madrigal PharmaceuticalsMDGL · Health Care | AED 2.2B | AED 35.1B | AED 1,512.61 | 2.41% down | 24% down | ||
| 22 | Protagonist TherapeuticsPTGX · Health Care | AED 2.3B | AED 29.9B | AED 457.86 | 0.01% down | 46% up | ||
| 23 | Cogent BiosciencesCOGT · Health Care | AED 2.3B | AED 18.3B | AED 105.06 | 2.71% up | 20% down | ||
| 24 | Corcept TherapeuticsCORT · Health Care | AED 2.4B | AED 27.6B | AED 252.20 | 2.01% down | 8% down | ||
| 25 | TG TherapeuticsTGTX · Health Care | AED 2.4B | AED 35.6B | AED 235.40 | 2.20% up | 107% up | ||
| 26 | Summit TherapeuticsSMMT · Health Care | AED 2.4B | AED 31.9B | AED 39.85 | 1.69% up | 36% down | ||
| 27 | Spyre TherapeuticsSYRE · Health Care | AED 2.6B | AED 33.2B | AED 349.37 | 1.40% up | 286% up | ||
| 28 | InsmedINSM · Health Care | AED 2.7B | AED 96.7B | AED 440.78 | 1.52% down | 40% down | ||
| 29 | Belite BioBLTE · Health Care | AED 2.8B | AED 23.7B | AED 584.58 | 0.91% up | 31% up | ||
| 30 | Alnylam PharmaceuticalsALNY · Health Care | AED 2.9B | AED 75.4B | AED 563.15 | 2.03% down | 66% down | ||
| 31 | Praxis Precision MedicinesPRAX · Health Care | AED 3.2B | AED 31.4B | AED 1,121.63 | 0.10% up | 61% up | ||
| 32 | Legend BiotechLEGN · Health Care | AED 3.7B | AED 11.6B | AED 59.56 | 0.65% up | 42% down | ||
| 33 | Ligand PharmaceuticalsLGND · Health Care | AED 3.7B | AED 22B | AED 1,100.93 | 2.02% up | 43% up | ||
| 34 | AlkermesALKS · Health Care | AED 6.7B | AED 28.8B | AED 171.38 | 2.66% up | 58% up | ||
| 35 | ZoetisZTS · Health Care | AED 12.2B | AED 125.3B | AED 308.32 | 0.56% up | 29% down | ||
| 36 | Dr. Reddy's LaboratoriesRDY · Health Care | AED 14.7B | AED 45.9B | AED 55.04 | 1.32% up | 5% up | ||
| 37 | Jazz PharmaceuticalsJAZZ · Health Care | AED 15.9B | AED 57.5B | AED 895.34 | 1.27% up | 37% up | ||
| 38 | BeOne MedicinesONC · Health Care | AED 16B | AED 169.7B | AED 1,485.95 | 2.10% down | 17% up | ||
| 39 | Roivant SciencesROIV · Health Care | AED 16.6B | AED 103.4B | AED 142.66 | 0.34% up | 90% up | ||
| 40 | GenmabGMAB · Health Care | AED 21.5B | AED 116.5B | AED 188.97 | 0.98% down | 70% up | ||
| 41 | GrifolsGRFS · Health Care | AED 21.5B | AED 21.4B | AED 31.42 | 0.87% down | 1% up | ||
| 42 | BioMarin PharmaceuticalBMRN · Health Care | AED 22.4B | AED 42.8B | AED 221.07 | 2.87% up | 11% up | ||
| 43 | Elanco Animal HealthELAN · Health Care | AED 24B | AED 48.5B | AED 97.04 | 2.21% up | 20% up | ||
| 44 | United TherapeuticsUTHR · Health Care | AED 26.1B | AED 89.8B | AED 2,109.40 | 1.68% down | 23% up | ||
| 45 | Teva Pharmaceutical IndustriesTEVA · Health Care | AED 29.1B | AED 181.8B | AED 155.80 | 0.47% down | 74% up | ||
| 46 | Royalty PharmaRPRX · Health Care | AED 35.7B | AED 144.7B | AED 251.74 | 0.20% down | 78% up | ||
| 47 | ViatrisVTRS · Health Care | AED 54B | AED 87.3B | AED 76.16 | 1.39% up | 96% up | ||
| 48 | Bristol-Myers SquibbBMY · Health Care | AED 67.8B | AED 449.7B | AED 220.01 | 2.36% down | 34% up | ||
| 49 | Vertex PharmaceuticalsVRTX · Health Care | AED 68.6B | AED 498.1B | AED 1,964.71 | 0.13% up | 27% up | ||
| 50 | GSKGSK · Health Care | AED 79.8B | AED 359.8B | AED 179.49 | 0.75% down | 6% up | ||
| 51 | Eli LillyLLY · Health Care | AED 97.5B | AED 4.55T | AED 5,102.91 | 1.85% down | 35% up | ||
| 52 | Novo NordiskNVO · Health Care | AED 105.8B | AED 643.5B | AED 146.02 | 2.32% down | 17% down | ||
| 53 | Regeneron PharmaceuticalsREGN · Health Care | AED 114.8B | AED 363.1B | AED 3,510.15 | 0.22% down | 36% up | ||
| 54 | NovartisNVS · Health Care | AED 169.4B | AED 1.08T | AED 574.11 | 1.77% down | 25% up | ||
| 55 | Takeda PharmaceuticalTAK · Health Care | AED 170.9B | AED 250.8B | AED 78.51 | 1.22% down | 54% up | ||
| 56 | AstraZenecaAZN · Health Care | AED 178.7B | AED 1.02T | AED 657.69 | 1.76% down | 2% up | ||
| 57 | Abbott LaboratoriesABT · Health Care | AED 191.5B | AED 662.4B | AED 382.48 | 0.55% down | 17% down | ||
| 58 | Merck & CoMRK · Health Care | AED 193.2B | AED 1.26T | AED 512.70 | 2.64% down | 51% up | ||
| 59 | SanofiSNY · Health Care | AED 290.9B | AED 417.1B | AED 173.69 | 0.50% down | 4% down | ||
| 60 | Johnson & JohnsonJNJ · Health Care | AED 299.5B | AED 2.43T | AED 1,010.75 | 1.26% down | 38% up | ||
| 61 | PfizerPFE · Health Care | AED 317.6B | AED 589.8B | AED 103.48 | 1.04% down | 14% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6729 AED).
Questions and answers
Which pharmaceuticals have the lowest net assets?
AbbVie (-AED 12B), BridgeBio Pharma (-AED 7.7B) and Cytokinetics (-AED 2.4B) have the lowest net assets of the 61 pharmaceuticals ranked here as of 18 Nov 2026, 16:06 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by net assets.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by net assets have a combined market value of AED 18.68T as of 18 Nov 2026, 16:06 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.